ARCHIVES

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

This article is from The Cancer Letter archive.

Vol. 36 No. 33 | September 17, 2010

Download PDF Visit The Full Archive

Related Articles

NCI To Recompete NSABP in 1995, Chabner tells Senate

May 20, 1994

FDA Accepts Advisory Committee’s Recommendations On NDA, Labeling

October 26, 1979

Blood Cancers Advocacy Groups Seek DOD And NCI Funds, Medicare Coverage.

July 6, 2001

NCI to Ask Cancer Panel, NCAB, to Help Respond To Request for Review Of National Cancer Program

December 4, 1992

NCI Bypass Budget For FY99 Proposes Expansion of Cancer Clinical Trials System

December 5, 1997

In Brief: Reauthorization May Be Wrapped Up This Week As House, Senate Work Toward Compromise

October 14, 1988